Semaglutide and others in its class are currently being evaluated for treatment of liver and kidney diseases, substance use disorders, and dementia
At-home diagnostics can help reduce employer costs for GLP-1s 43% of employers plan to cover GLP-1 drugs in 2024, and companies already covering them say they plan to continue doing so
Most commercial insurance plans cover GLP-1s for diabetes management, but fewer cover them for weight management
Oh, I'm just not solving any problems So I had to turn my career to a completely different angle no former educations in in making medications or doing compounding or customizing medications that dive into the that practice and 25 years later here we are today and looking back at that and said, what a journey, what a turning point I had, because it shaped me for who I am today
So can you tell us a little bit about how the first signs of diabetes might affect the bladder
Keep your follow-up appointments